Diagnostics and Therapeutics for Autism Spectrum Disorders: Global Markets

Report Code: HLC181A

Publish Date: Mar 2015

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Use code SUMMER at checkout for 50% OFF

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global autism spectrum disorders (ASD) market was valued at $346.2 million in 2013 and $360.9 million in 2014. This market is expected to grow to $412.7 million by 2019, a compound annual growth rate (CAGR) of 2.7%.

Report Includes

  • An overview of the regional and global markets for Autism Spectrum Disorder (ASD) therapies and diagnostics.
  • Analyses of global market trends, with data from 2013, 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • An overview of ASDs including types, epidemiology, symptoms, and causes and pathophysiology.
  • Coverage of approved therapies and tolerated off-label alternative treatments for ASD. 
  • In-depth analysis of the ASD therapies market dynamics, specifically growth drivers, inhibitors, and opportunities.
  • A relevant patent analysis including patents nearing expiration, and recently issued patents.
  • Comprehensive profiles of major players in the field.

SCOPE OF THE STUDY

The scope of this study encompasses the global and regional markets for therapeutic and diagnostic technologies of ASD. BCC Research analyzed each market and its applications, regulatory environment, technology, market projections and market share. Issues discussed include the major drug profiles, technological features and trends. The global markets for the ASD therapeutics and diagnostics include selected markets in the U.S., Canada, the U.K., France, Germany, Spain, Italy and Japan. The markets of the rest of the world are not reported due to their economic insignificance for this report.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

Ufuk Ezer. Ezer holds a bachelor's degree in bioengineering and a master's degree in biotechnology, bioprocessing and business management. He possesses extensive pharmaceutical research and development experience and has participated in projects for various international institutions and organizations. Ezer has been granted scholarships and awards during his post-study works in countries such as Japan and Panama based on the high quality of his work and excellence in the fields of research.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Diagnostics and Therapeutics for Autism Spectrum Disorders: Global Markets163Free
Chapter- 1: Introduction3Free
Chapter- 2: SUMMARY4Free
Chapter- 3: OVERVIEW13Free
Chapter- 4: REGULATORY LANDSCAPE5Free
Chapter- 5: GLOBAL MARKETS46Free
Chapter- 6: MARKETS IN NORTH AMERICA22Free
Chapter- 7: MARKETS IN EUROPE20Free
Chapter- 8: MARKETS IN JAPAN15Free
Chapter- 9: PIPELINE ASSESSMENT15Free
Chapter- 10: DIAGNOSTIC TECHNOLOGIES: RECENT DEVELOPMENTS9Free
Chapter- 11: C. CRAMER & CO. GMBH11Free

Related Reports

Drugs for Treating Mental Disorders: Technologies and Global Markets

Published - Feb 2014 | Publisher - Shalini Shahani Dewan | Code - PHM074B

The global market for drugs used in mental disorders was $70.1 billion in 2012 and $68.9 billion in 2013. This market is expected to rise at a compound annual growth rate (CAGR) of 2.3% from 2013 to 2018 and reach $77.1 billion by 2018.

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

Published - Mar 2013 | Publisher - Jackson Highsmith | Code - BIO074B

The global CNS biomarker market was estimated at $1.7 billion in 2011 and nearly $2 billion in 2012. The market is projected to reach $5.1 billion by the end of the forecast period of 2012 to 2017, representing a compound annual growth rate (CAGR) of 20.7%.

Recent Reports

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - HLC176E

The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.

Routine Health Screening Market

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC299A

The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.

Elder Care Services and Assistive Devices: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC062E

The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.

Direct-to-Consumer Testing Industry: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC269B

The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

Health and Medical Insurance Providers: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC212B

The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Hydrogen Storage: Materials, Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - EGY146C

The global market for hydrogen storage materials and technologies is expected to grow from $5.3 billion in 2023 to $7.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Solid State Batteries: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - FCB053B

The global market for solid state batteries is estimated to increase from $274.0 million in 2023 to reach $1.7 billion by 2029, at a compound annual growth rate (CAGR) of 36.7% from 2024 through 2029.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Plastics Recycling: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - PLS031E

The global market for plastic recycling is expected to grow from $42.4 billion in 2024 to $57.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Diagnostics and Therapeutics for Autism Spectrum Disorders: Global Markets
Customize Report